Jump in the discussion.

No email address required.

>For adolescents with gender incongruence, the [National Board of Health and Welfare] deems that the risks of puberty suppressing treatment with GnRH-analogues and gender-affirming hormonal treatment currently outweigh the possible benefits, and that the treatments should be offered only in exceptional cases. … To minimize the risk that a young person with gender incongruence later will regret a gender-affirming treatment, the NBHW deems that the criteria for offering GnRH-analogue and gender-affirming hormones should link more closely to those used in the Dutch protocol, where the duration of gender incongruence over time is emphasized

I'm more surprised this is from Sweden, aka "idgaf" the country, than anything else said here

Jump in the discussion.

No email address required.

Why are Americans surprised that a system with socialized medicine doesnt bow to corporate trends

Jump in the discussion.

No email address required.

lol even a doc from the dutch institute that started all these nonsense has already raised concerns but some people just pretend to not hear or see it

Jump in the discussion.

No email address required.

Link copied to clipboard
Action successful!
Error, please refresh the page and try again.